Small and medium ent的問題,透過圖書和論文來找解法和答案更準確安心。 我們找到下列免費下載的地點或者是各式教學

另外網站small or medium enterprise - Chinese translation也說明:Many translated example sentences containing "small or medium enterprise" – Chinese-English dictionary and search engine for Chinese translations.

國立臺東大學 應用科學系 朱見和、朱見和所指導 蕭普晏的 鈀金屬催化自身脫氫偶聯策略合成吡唑并[1,5-a]吡啶雙聚物暨其聚集螢光誘導增強效應研究 (2021),提出Small and medium ent關鍵因素是什麼,來自於吡唑并[1、5-a]吡啶、鈀金屬催化、碳-氫鍵活化、自身脫氫偶聯偶合反應。

而第二篇論文中國醫藥大學 生技製藥產業博士學位學程 翁豐富、莊宗原所指導 曾敬錞的 合成含氮五元雜環化合物暨光物理性質與生物活性之研究 附錄: Vonoprazan Fumarate之製程開發 (2021),提出因為有 一鍋化合成、微波合成、吡唑、魯米諾類似物、雙基胜肽酶抑制劑、1,2,4-三唑、西格列汀類似物的重點而找出了 Small and medium ent的解答。

最後網站OGGO - Small and Medium Enterprises (SME) in Federal ...則補充:The Committee is undertaking a study on federal procurement in relation to small and medium enterprises (SME) and how the federal government could improve ...

接下來讓我們看這些論文和書籍都說些什麼吧:

除了Small and medium ent,大家也想知道這些:

鈀金屬催化自身脫氫偶聯策略合成吡唑并[1,5-a]吡啶雙聚物暨其聚集螢光誘導增強效應研究

為了解決Small and medium ent的問題,作者蕭普晏 這樣論述:

A facile methodology for the synthesis of 7,7’-diaryl-3,3’-bipyrazolo[1,5-a]pyridine via Pd-catalyzed C-H/C-H cross-coupling strategy was presented. Good functional group tolerance was observed as well as modest to good yields were given. The reaction mechanism was carefully investigated by a serie

s of control experiments and DFT calculations. The synthetic expansion was demonstrated by employing 7,7’-dipheny-3,3’-bipyrazolo[1,5-a]pyridine as an example. Furthermore, photophysical properties of these compounds were measured that showed good to excellent aggregation-induced emission enhancemen

t effects.

合成含氮五元雜環化合物暨光物理性質與生物活性之研究 附錄: Vonoprazan Fumarate之製程開發

為了解決Small and medium ent的問題,作者曾敬錞 這樣論述:

List of ContentsAcknowledgments...IPublication List...II中文摘要...VAbstract...VIAbbreviations...VIIList of Contents...IXList of Figures...XIList of Schemes...XVList of Tables...XVIChapter 1. Introduction...11.1 Biological activities of five-membered heterocycles...11.1.1 Biological activities of 6-ami

nopyrazolo[3,4-d]pyrimidine derivatives...21.1.2 Biological activities of pyrazolopyridine derivatives...81.2 Luminescence property of pyrazole-fused derivatives...121.3 Biological activities of triazole derivatives...151.3.1 Diabetes mellitus...151.3.2 Dipeptidyl peptidase-4 inhibitors...21Chapter

2. Research Approach...25Chapter 3. Results & Discussion...283.1 One-Pot Acid-promoted Synthesis of 6-Aminopyrazolopyrimidines from 1H-Pyrazol-5-yl-N,N-dimethylformamidines or 5-Amino-1H-pyrazole-4-carbaldehydes with Cyanamide...283.1.1 Introduction...283.1.2 Results and discussion...313.1.3 Conclus

ion...423.1.4 Experimental Section...433.2 Selective Synthesis and Photoluminescence Study of Pyrazolopyridopyridazine Diones and N-Aminopyrazolopyrrolopyridine Diones...573.2.1 Introduction...573.2.2 Results and discussion...593.2.3 Conclusion...723.2.4 Experimental Section...733.3 Design, Synthesi

s, and Biological Evaluation of Glycolamide, Glycinamide, and β-Amino Carbonyl Derivatives Containing 1,2,4-Triazole as DPP-4 Inhibitors...853.3.1 Introduction...853.3.2 Results and discussion...883.3.3 Conclusion...1103.3.4 Experimental Section...112Chapter 4. Conclusion...148Chapter 5. Future Work

...150Chapter 6. References...152Chapter 7. Spectrum...1707.1 One-Pot Acid-promoted Synthesis of 6-Aminopyrazolo pyrimidines from 1H-Pyrazol-5-yl-N,N-dimethylformamidines or 5-Amino-1H-pyrazole-4-carbaldehydes with Cyanamide...1707.2 Synthesis and Photoluminescence Study of Pyrazolopyrido pyridazine

diones and N-Aminophthalimides as Luminol Analogues...2087.3 Design, Synthesis, and Biological Evaluation of Novel Glycolamide and Glycinamide Containing 1,2,4-Triazole Derivatives as DPP-4 Inhibitors...246